Can functional oligosaccharides reduce the risk of diabetes mellitus?
Open Access
- 15 August 2019
- journal article
- review article
- Published by Wiley in The FASEB Journal
- Vol. 33 (11) , 11655-11667
Abstract
Diabetes significantly affects the life quality and length of patients with diabetes, and almost half of the 4 million people who die from diabetes are under the age of 60. Because of the increasing number of patients with diabetes and the side effects of antidiabetic drugs, the search for new dietary supplementation from natural resources, especially functional oligosaccharides, has attracted much attention among scientific researchers. Functional oligosaccharides are potential antidiabetic treatments because of their nondigestible, low‐calorie, and probiotic features. The antidiabetic activity of multiple functional oligosaccharides such as fructo‐oligosaccharides, galacto‐oligosaccharides, and xylo‐oligosaccharides has been reviewed in this paper. Molecular mechanisms involved in the antidiabetic activity of oligosaccharides have been systematically discussed from multiple perspectives, including the improvement of pancreas function, α‐glucosidase inhibition, the relief of insulin and leptin resistance, anti‐inflammatory effects, regulation of gut microbiota and hormones, and the intervention of diabetic risk factors. In addition, the antidiabetic effects of functional oligosaccharides through the complex gut‐brain‐liver axis are summarized. The concepts addressed in this review have important clinical implications, although more works are needed to confirm the antidiabetic mechanisms of functional oligosaccharides, standardize safe dose levels, and clarify their metabolism in the human body.—Zhu, D., Yan, Q., Liu, J., Wu, X., Jiang, Z. Can functional oligosaccharides reduce the risk of diabetes mellitus? FASEB J. 33, 11655‐11667 (2019). www.fasebj.orgKeywords
This publication has 117 references indexed in Scilit:
- Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control studyBMC Medicine, 2013
- Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese womenGut, 2012
- Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein–Coupled Receptor FFAR2Diabetes, 2012
- Mini-Special Issue paper Management of diabetic patients with hypoglycemic agents α-Glucosidase inhibitors and their use in clinical practiceArchives of Medical Science, 2012
- Responses of Gut Microbiota and Glucose and Lipid Metabolism to Prebiotics in Genetic Obese and Diet-Induced Leptin-Resistant MiceDiabetes, 2011
- Angiotensin-I-Converting Enzyme (ACE) Inhibitors from Marine Resources: Prospects in the Pharmaceutical IndustryMarine Drugs, 2010
- High-Fat Diet Determines the Composition of the Murine Gut Microbiome Independently of ObesityGastroenterology, 2009
- Antihypertensive Properties of Plant-Based PrebioticsInternational Journal of Molecular Sciences, 2009
- Innate immunity and intestinal microbiota in the development of Type 1 diabetesNature, 2008
- Mechanisms underlying the resistance to diet-induced obesity in germ-free miceProceedings of the National Academy of Sciences of the United States of America, 2007